Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (91-100 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|February 24, 2006
[The IDEAL study comparing simvastatin 20-40 mg versus atorvastatin 80 mg for secondary prevention after myocardial infarction: between two ideas of the ideal]A J Scheen
Revue Medicale De Liege|January 15, 1999
[Drug clinics. Drug of the month. Formoterol (Oxis turbohaler)]A J Scheen
Revue Medicale De Liege|November 12, 1998
[Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances]A J Scheen
Revue Medicale De Liege|December 3, 1998
[Therapeutic update 1997-1998]A J Scheen
Diabetes & Metabolism|November 7, 1998
[Role of acarbose in the treatment of diabetes mellitus]A J Scheen
Revue Medicale De Liege|March 1, 1996
[How I explore... metabolic disorders in menopausal women]A J Scheen
Revue Medicale De Liege|March 1, 1996
[Pharma-clinics. Drug of the month. Polyvalent antipneumococcal vaccine (Pneumune)]A J Scheen
Revue Medicale De Liege|August 17, 2006
[Drug interactions: from theory to practice]A J Scheen
Revue Medicale De Liege|February 3, 2009
[JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein]A J Scheen
Diabetologia|April 21, 2009
Rosiglitazone: to be or not to be?A J Scheen
Pageof 79

Showing results (91-100 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|February 24, 2006
[The IDEAL study comparing simvastatin 20-40 mg versus atorvastatin 80 mg for secondary prevention after myocardial infarction: between two ideas of the ideal]A J Scheen
Revue Medicale De Liege|January 15, 1999
[Drug clinics. Drug of the month. Formoterol (Oxis turbohaler)]A J Scheen
Revue Medicale De Liege|November 12, 1998
[Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances]A J Scheen
Revue Medicale De Liege|December 3, 1998
[Therapeutic update 1997-1998]A J Scheen
Diabetes & Metabolism|November 7, 1998
[Role of acarbose in the treatment of diabetes mellitus]A J Scheen
Revue Medicale De Liege|March 1, 1996
[How I explore... metabolic disorders in menopausal women]A J Scheen
Revue Medicale De Liege|March 1, 1996
[Pharma-clinics. Drug of the month. Polyvalent antipneumococcal vaccine (Pneumune)]A J Scheen
Revue Medicale De Liege|August 17, 2006
[Drug interactions: from theory to practice]A J Scheen
Revue Medicale De Liege|February 3, 2009
[JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein]A J Scheen
Diabetologia|April 21, 2009
Rosiglitazone: to be or not to be?A J Scheen
Pageof 79